Previous COVID-19 Tied to Increased Risk for Kidney Disease
via HealthDayTHURSDAY, March 5, 2026 -- Past COVID-19 illness increases the risk for kidney disease compared with individuals without COVID-19 and those with past flu infection, according to a study published online Feb. 25 in Communications Medicine.
Yue Zhang, Ph.D., from Penn State College of Medicine in Hershey, and colleagues examined the association between COVID-19 infection and subsequent kidney disease. The analysis included 939,241 individuals with COVID-19, ~1.9 million individuals in the negative control group, and 199,071 individuals with influenza identified from the MarketScan database (January 2020 to December 2021).
The researchers found that COVID-19 was significantly associated with an increased risk for acute kidney injury (AKI; adjusted hazards ratio [aHR], 2.74), chronic kidney disease (CKD; aHR, 1.38), end-stage renal disease (ESRD; aHR, 3.22), and glomerular disease (aHR,1.28). In contrast, influenza had no impact on CKD, ESRD, or glomerular diseases. COVID-19 had stronger effects on AKI in the short term but had stable long-term effects on CKD.
"Individuals with COVID-19 infection may need more frequent and more prolonged monitoring of their kidney function to enable earlier detection and possible preventative interventions," coauthor Nasr Ghahramani, MD, also from Penn State College of Medicine, said in a statement. "This is particularly important for individuals who have predisposing factors for kidney disease such as diabetes and high blood pressure."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-03-06 02:13
Read more
- Pfizer’s Ultra-Long-Acting Injectable GLP-1 RA PF’3944 Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial
- Review of U.S. Measles Elimination Status Delayed Until November
- Ultra-Endurance Running Accelerates Red Blood Cell Aging
- Lindsey Vonn Says Olympic Crash Nearly Cost Her a Leg
- Theravance Biopharma Reports Phase 3 CYPRESS Study of Ampreloxetine Did Not Meet Primary Endpoint
- Zepbound (tirzepatide) Now Available in Multi-Dose KwikPen
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions